INR:4782. mpl rummy download Nat Immunol discovers the relationship between intestinal microbes and the immune system Major breakthrough! AI predicts powerful ...
Below, The i Paper lists ten ways you can make £1,000 – or more – in 2025. This is an easy way to make money if you have a driveway at your home. Britons opting to do this make an average of £330 a ...
Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence Biomed” or the "Company”) today announced that it has closed its previously ...
Opinion
philstar.com22 小时Opinion
Fixing a bad budget
One of the solutions being offered to fix the present budget debacle is to return the “very, very bad budget” – in the words of presidential sister Senator Imee Marcos – to Congress to address the ...
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it has entered into a securities purchase agreement for a private investment in public equity ...
(the “Company” and “Castellum”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, today announced the pricing of its ...
Vor Bio (VOR) has entered into a securities purchase agreement for a private investment in public equity financing that is expected to result ...
The aggregate gross proceeds to the Company from the offering are expected to be approximately $4 million, before deducting the placement agent fees and other offering expenses payable by the Company.
First Carolina Financial Services, the parent company of First Carolina Bank, announced recently the completion of a private ...
The offering resulted in total gross proceeds of approximately US$10 million (“Gross Proceeds”), before deducting fees and offering expenses payable by the Company. The Company has successfully closed ...
Additionally, a Registered Direct Offering was conducted simultaneously, where Applied Optoelectronics issued 1,036,458 shares of Common Stock at a purchase price of $33.97 per share, generating net ...
OS Therapies, Inc. (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology c ...